Cargando…

Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan

Background: Mucopolysaccharidosis II (MPS II) is an X-linked disorder resulting from a deficiency in lysosomal enzyme iduronate-2-sulfatase (IDS), which causes the accumulation of glycosaminoglycans (GAGs) in the lysosomes of many tissues and organs, leading to progressive cellular dysfunction. An M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hsiang-Yu, Chang, Ya-Hui, Lee, Chung-Lin, Tu, Yuan-Rong, Lo, Yun-Ting, Hung, Pei-Wen, Niu, Dau-Ming, Liu, Mei-Ying, Liu, Hsin-Yun, Chen, Hsiao-Jan, Kao, Shu-Min, Wang, Li-Yun, Ho, Huey-Jane, Chuang, Chih-Kuang, Lin, Shuan-Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320252/ https://www.ncbi.nlm.nih.gov/pubmed/35887520 http://dx.doi.org/10.3390/jpm12071023

Ejemplares similares

A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
por: Lin, Shuan-Pei, et al.
Publicado: (2013)

Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the “Gold Standard” Criteria Required to Make a Confirmatory Diagnosis
por: Chuang, Chih-Kuang, et al.
Publicado: (2021)

Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan
por: Chuang, Chih-Kuang, et al.
Publicado: (2018)

An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study
por: Chuang, Chih-Kuang, et al.
Publicado: (2017)

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
por: Lin, Hsiang-Yu, et al.
Publicado: (2018)

Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995–2012
por: Lin, Hsiang-Yu, et al.
Publicado: (2016)

Efficacy of Intravenous Elosulfase Alfa for Mucopolysaccharidosis Type IVA: A Systematic Review and Meta-Analysis
por: Lee, Chung-Lin, et al.
Publicado: (2022)

Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA
por: Lin, Hsiang-Yu, et al.
Publicado: (2014)

Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II
por: Lin, Hsiang-Yu, et al.
Publicado: (2021)

Endoscopic and Image Analysis of the Airway in Patients with Mucopolysaccharidosis Type IVA
por: Lee, Yi-Hao, et al.
Publicado: (2023)

Wiedemann–Steiner Syndrome with a Pathogenic Variant in KMT2A from Taiwan
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Identification and Functional Characterization of IDS Gene Mutations Underlying Taiwanese Hunter Syndrome (Mucopolysaccharidosis Type II)
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Quantification of Idua Enzymatic Activity Combined with Observation of Phenotypic Change in Zebrafish Embryos Provide a Preliminary Assessment of Mutated idua Correlated with Mucopolysaccharidosis Type I
por: Lin, Cheng-Yung, et al.
Publicado: (2022)

Clinical characteristics and surgical history of Taiwanese patients with mucopolysaccharidosis type II: data from the hunter outcome survey (HOS)
por: Lin, Hsiang-Yu, et al.
Publicado: (2018)

Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants
por: Chuang, Chih-Kuang, et al.
Publicado: (2022)

Effect of Mutated ids Overexpression on IDS Enzyme Activity and Developmental Phenotypes in Zebrafish Embryos: A Valuable Index for Assessing Critical Point-Mutations Associated with Mucopolysaccharidosis Type II Occurrence in Humans
por: Lin, Cheng-Yung, et al.
Publicado: (2020)

22q11.2 Deletion Syndrome in Taiwan: Clinical Presentation and Immune System Status of Patients
por: Lee, Chung-Lin, et al.
Publicado: (2023)

Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series
por: Lin, Hsiang-Yu, et al.
Publicado: (2016)

Long-Term Cardiovascular Findings in Williams Syndrome: A Single Medical Center Experience in Taiwan
por: Lee, Chung-Lin, et al.
Publicado: (2022)

Incidence and treatment of adult femoral fractures with osteogenesis imperfecta: An analysis of a center of 72 patients in Taiwan
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Increased Diagnostic Yield of Array Comparative Genomic Hybridization for Autism Spectrum Disorder in One Institution in Taiwan
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update
por: Burton, Barbara K., et al.
Publicado: (2020)

Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2013)

The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses
por: Lin, Hsiang‐Yu, et al.
Publicado: (2018)

Health Belief, Behavior Intention, and Health Behaviors Related to Colorectal Cancer Screening in Taiwan
por: Lin, I-Pei, et al.
Publicado: (2020)

Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A Syndrome
por: Lee, Chung-Lin, et al.
Publicado: (2022)

The first SHORT syndrome in a Taiwanese boy: A case report and review of the literature
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta
por: Lin, Hsiang-Yu, et al.
Publicado: (2015)

Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience
por: Clarke, Lorne A., et al.
Publicado: (2020)

Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I
por: Dorley, M. Christine, et al.
Publicado: (2023)

Parenting Confidence and Needs for Parents of Newborns in Taiwan
por: Kuo, Ching-Pyng, et al.
Publicado: (2012)

Fabry Disease and the Effectiveness of Enzyme Replacement Therapy (ERT) in Left Ventricular Hypertrophy (LVH) Improvement: A Review and Meta-Analysis
por: Lee, Chung-Lin, et al.
Publicado: (2022)

Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan
por: Chien, Yin-Hsiu, et al.
Publicado: (2022)

Breastmilk as a Multisensory Intervention for Relieving Pain during Newborn Screening Procedures: A Randomized Control Trial
por: Lan, Hsiang-Yun, et al.
Publicado: (2021)

Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Completeness and timeliness of tuberculosis notification in Taiwan
por: Lo, Hsiu-Yun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5l8q88j7s4bq01vu7cabtrafp3